Industry: EMA Needs to Focus on Real-World Evidence for Tracking Pharmacovigilance

Drug Industry Daily
A A
The European Medicines Agency should focus on real-world evidence and big data to assess the impact of the agency’s pharmacovigilance activities on industry.

To View This Article:

Login

Subscribe To Drug Industry Daily